Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 90, Issue 9, 2002, Pages 1020-1022

  Runquist, Lars H ^a,b   Nielsen, Christopher D ^a   Killip, Donna ^a   Gazes, Peter ^a   Spencer III, William H ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL SEPTAL ABLATION THERAPY; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LOCAL THERAPY; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; QRS COMPLEX; SYMPTOM; TREATMENT OUTCOME;

BUNDLE-BRANCH BLOCK; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ELECTROCARDIOGRAPHY; ETHANOL; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART SEPTUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 0036829375     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02693-0     Document Type: Article

References (13)

1. Ruzyllo W., Chojnowska L., Demkow M., Witkowski A., KuSmierczyk-Droszcz B., Piotrowski W., Rausinska L., Karcz M., Malecka L., Rydlewska-Sadowska W. Left ventricular outflow tract gradients decrease with nonsurgical myocardial reduction improves exercise capacity in patients with hypertrophic cardiomyopathy. Eur Heart J. 21:2000;770-777.
2. Seggewiss H., Faber L., Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg. 47:1999;94-100.
3. Kazmierczak J., Kornacewicz-Jach Z., Kisly M., Gil R., Wojtarowicz A. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Heart. 80:1998;257-262.
4. Henein M.Y., O'Sullivan C.A., Ramzy I.S., Sigwart U., Gibson D.G. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 34:1999;1117-1122.
5. Lakkis N.M., Nagueh S.F., Dunn J.K., Killip D., Spencer W.H. III. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy one-year follow-up . J Am Coll Cardiol. 36:2000;852-855.
6. Romhilt D.W., Estes E.H. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 75:1968;752-758.
7. Gietzen F.H., Leuner C.J., Raute-Kreinsen U., Dellmann A., Hegselmann J., Strunk-Mueller C., Kuhn H.J. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 20:1999;1342-1354.
8. Dollar AL, Roberts WC. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy. Am J Med 1989;87:377-381.
9. Lakkis N.M., Nagueh S.F., Kleiman N.S., Killip D., He Z.X., Verani M.S., Roberts R., Spencer W.H. III. Echocardiographic guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 98:1998;1750-1755.
10. Mazur W., Nagueh S.F., Lakkis N.M., Middleton K.J., Killip D., Roberts R., Spencer W.H. III. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 103:2001;1492-1496.
11. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 342:2000;1778-1785.
12. Nagueh S.F., Stetson S.J., Lakkis N.M., Killip D., Perez-Verdia A., Entman M.L., Spencer W.H. III, Torre-Amione G. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 103:2001;1844-1850.
13. Nagueh S.F., Lakkis N.M., Middleton K.J., Killip D., Zoghbi W.A., Quinones M.A., Spencer W.H. III. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 34:1999;1123-1128.